BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
CLSA re-initiates Ipca Laboratories with buy
CLSA says US FDA issue is a small roadblock and US FDA resumption is a big trigger. Company has strong capabilities to navigate transition phase, adds CLSA.